Recommended BMD Screening Schedule for a 70-Year-Old Woman
A 70-year-old woman should undergo initial DEXA bone mineral density screening now if not previously done, with follow-up intervals ranging from 1-15 years depending on her baseline T-score results.
Initial Screening Recommendation
At age 70, this woman falls squarely within the universal screening recommendation window. All women aged ≥65 years should undergo DXA BMD measurement at the lumbar spine, total hip, femoral neck, and if indicated, one-third radius 1. This recommendation is consistently supported across major guidelines, including the 2025 USPSTF statement 2 and multiple professional societies.
Follow-Up Screening Intervals Based on Initial Results
The rescreening interval should be determined by the baseline T-score, not arbitrarily set:
Normal Bone Density (T-score ≥ -1.0)
- Repeat screening in approximately 15 years 3
- Only 10% of women in this category will transition to osteoporosis within 16.8 years (95% CI: 11.5-24.6 years)
Mild Osteopenia (T-score -1.01 to -1.49)
- Repeat screening in approximately 15 years 3
- Transition time to osteoporosis: 17.3 years (95% CI: 13.9-21.5 years)
Moderate Osteopenia (T-score -1.50 to -1.99)
- Repeat screening in 4-5 years 3
- Transition time to osteoporosis: 4.7 years (95% CI: 4.2-5.2 years)
Advanced Osteopenia (T-score -2.00 to -2.49)
- Repeat screening annually 3
- Transition time to osteoporosis: 1.1 years (95% CI: 1.0-1.3 years)
Osteoporosis (T-score ≤ -2.5)
- If treatment initiated: repeat in 1-2 years, then every 1-5 years depending on clinical response 1
- More frequent monitoring may be warranted based on treatment response and clinical circumstances
Important Clinical Considerations
The 2025 guidelines acknowledge that evidence on optimal screening intervals remains limited 2, but the data from Gourlay et al. provides the best available framework for risk-stratified rescreening 3. The suggested intervals of 1-5 years between BMD testing in clinical practice may be influenced by the patient's clinical state, national guidelines, cost, and reimbursement 1.
Key Caveats:
- Clinical risk factors matter: While T-scores guide intervals, the presence of additional risk factors (glucocorticoid use, height loss >4 cm, prevalent fractures, secondary causes of osteoporosis) may warrant more frequent monitoring 1, 4
- Same facility, same machine: Follow-up scans should ideally be performed at the same facility with the same DXA system to minimize precision errors 1
- Vertebral fracture assessment (VFA): Consider VFA at baseline if T-score < -1.0, historical height loss >4 cm, or other specific risk factors 1
Common Pitfall to Avoid:
Do not automatically rescreen every 2 years regardless of baseline results—this leads to unnecessary testing in women with normal or mildly osteopenic bone density, while potentially under-screening those with advanced osteopenia who need annual monitoring 3.